Screener
Emergent Biosolutions EBS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $(180.2) | $(12.0) | $(173.4) | $56.0 |
| Earnings (loss) per common share | ||||
| Basic | $(3.49) | $(0.22) | $(3.35) | $1.03 |
| Diluted | $(3.49) | $(0.22) | $(3.35) | $0.99 |
| Weighted average shares outstanding | ||||
| Basic | 51.6 | 54.2 | 51.7 | 54.3 |
| Diluted | 51.6 | 54.2 | 51.7 | 56.7 |
| (1) Exclusive of intangible asset amortization |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's EPS (diluted)?
- Emergent Biosolutions (EBS) reported EPS (diluted) of -$3.49 in Q2 2026.
- How has Emergent Biosolutions's EPS (diluted) changed year-over-year?
- Emergent Biosolutions's EPS (diluted) decreased by 1486.4% year-over-year, from -$0.22 to -$3.49.
- What is the long-term trend for Emergent Biosolutions's EPS (diluted)?
- Over 3 years (2021 to 2024), Emergent Biosolutions's EPS (diluted) has grown at a -3.0% compound annual growth rate (CAGR), from $4.07 to -$3.72.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Emergent Biosolutions's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude